What is Opko Health's SG&A?

Opko Health (OPK) reported SG&A of $48.61M in Q1 2026.

How has Opko Health's SG&A changed year-over-year?

Opko Health's SG&A decreased by 17.7% year-over-year, from $59.09M to $48.61M.

What is the long-term trend for Opko Health's SG&A?

Over 3 years (2021 to 2025), Opko Health's SG&A has grown at a -21.9% compound annual growth rate (CAGR), from $468.86M to $223M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Opko Health OPK SG&A

SG&A at other companies

Quest DiagnosticsDGX

$504M+5.9%

HRO

HarrowHROW

$43.23M+6.7%

PrecigenPGEN

$21.05M+70.3%

Ultragenyx PharmaceuticalRARE

$88M+1.1%

AbbottABT

$3.74B+22.2%

Amneal Pharmaceuticals, Inc.AMRX

$138.86M+17.4%

Segments

By segment

See full

Diagnostics$26.15M-31.1%

Pharmaceutical$14.21M+11.8%

Other financials

Income statement

See full

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

See full

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

See full

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

See full

Market cap$1.13B+10.0%

P/S1.9×+0.5×

Profitability

See full

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

See full

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opko Health's SG&A?: Opko Health (OPK) reported SG&A of $48.61M in Q1 2026.
How has Opko Health's SG&A changed year-over-year?: Opko Health's SG&A decreased by 17.7% year-over-year, from $59.09M to $48.61M.
What is the long-term trend for Opko Health's SG&A?: Over 3 years (2021 to 2025), Opko Health's SG&A has grown at a -21.9% compound annual growth rate (CAGR), from $468.86M to $223M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.